Tianjin Medical University Cancer Institute and Hospital
Tianjin · Oncology · 3A · NCC
Fudan 2022 · #80 3A · NCC
Overview
Tianjin Medical University Cancer Institute and Hospital is a leading Chinese hospital located in Tianjin, China. It is included in the MedTravelCN Top 100 for its recognized strength in Oncology and its capacity to receive international patients.
One of China's earliest cancer hospitals (predecessor 1861); a National Clinical Research Center for Cancer.
Key information
| Founded | 1861 |
|---|---|
| City | Tianjin |
| Specialty focus | Oncology |
| Accreditation | 3A · NCC |
| Fudan 2022 rank | #80 |
Address & location
Leading departments
Ranking trend (Fudan ranking, tier reference)
2021
2022
2023
2024
2025
Tier bands compiled from Fudan China Hospital Ranking releases 2021-2025; for reference only.
Representative experts
- Prof. Hao Xishan · Oncology
- Hao Jihui · President; pancreatic oncology
- Zhang Jin · Breast cancer center
- Ba Yi · GI oncology
- Wang Ping · Former president; radiation oncology
- Hepatobiliary Oncology · Hepatobiliary oncology
Experts compiled from public sources and hospital websites; availability and titles may change — please verify with the hospital before booking.
News & milestones
One of China's earliest cancer hospitals, tracing to 1861
Milestones compiled from credible public reports and official releases; titles are summarized.
International cooperation & exchange
- International research cooperation; active global publications in breast and pancreatic cancer.
International cooperation information compiled from public reports; subject to the hospital's official releases.
University collaboration
Tianjin Medical University
Research & publications
Leads national standardization and early-screening programs.
Compiled from public sources as of October 2026. Please verify details on the hospital's official website before travel.